Financial Analysis: Remedent (OTCMKTS:REMI) vs. Lifevantage (NASDAQ:LFVN)

Remedent (OTCMKTS:REMIGet Free Report) and Lifevantage (NASDAQ:LFVNGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Remedent and Lifevantage’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Remedent N/A N/A N/A
Lifevantage 4.12% 34.67% 15.24%

Institutional & Insider Ownership

35.3% of Lifevantage shares are held by institutional investors. 20.7% of Lifevantage shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Remedent and Lifevantage”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Remedent $990,000.00 0.20 -$270,000.00 ($0.01) -1.00
Lifevantage $200.16 million 0.79 $2.94 million $0.69 18.15

Lifevantage has higher revenue and earnings than Remedent. Remedent is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Remedent has a beta of -0.02, meaning that its stock price is 102% less volatile than the S&P 500. Comparatively, Lifevantage has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Remedent and Lifevantage, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Remedent 0 0 0 0 0.00
Lifevantage 0 0 2 0 3.00

Lifevantage has a consensus price target of $30.50, suggesting a potential upside of 143.51%. Given Lifevantage’s stronger consensus rating and higher possible upside, analysts plainly believe Lifevantage is more favorable than Remedent.

Summary

Lifevantage beats Remedent on 14 of the 14 factors compared between the two stocks.

About Remedent

(Get Free Report)

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

About Lifevantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Receive News & Ratings for Remedent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Remedent and related companies with MarketBeat.com's FREE daily email newsletter.